000 01442 a2200409 4500
005 20250517122420.0
264 0 _c20180212
008 201802s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.12778
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJahn, Lorenz
245 0 0 _aGeneration of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies.
_h[electronic resource]
260 _bOncotarget
_cNov 2016
300 _a77021-77037 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntigens, CD20
_xgenetics
650 0 4 _aCD8-Positive T-Lymphocytes
_ximmunology
650 0 4 _aGenetic Therapy
650 0 4 _aHLA-A2 Antigen
_ximmunology
650 0 4 _aHumans
650 0 4 _aK562 Cells
650 0 4 _aLeukemia, B-Cell
_xgenetics
650 0 4 _aLymphoma, B-Cell
_xgenetics
650 0 4 _aReceptors, Antigen, T-Cell
_xgenetics
700 1 _avan der Steen, Dirk M
700 1 _aHagedoorn, Renate S
700 1 _aHombrink, Pleun
700 1 _aKester, Michel G D
700 1 _aSchoonakker, Marjolein P
700 1 _ade Ridder, Daniƫlle
700 1 _avan Veelen, Peter A
700 1 _aFalkenburg, J H Frederik
700 1 _aHeemskerk, Mirjam H M
773 0 _tOncotarget
_gvol. 7
_gno. 47
_gp. 77021-77037
856 4 0 _uhttps://doi.org/10.18632/oncotarget.12778
_zAvailable from publisher's website
999 _c26545623
_d26545623